Vaughn C. Embro-Pantalony - 01 Aug 2022 Form 3 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role: Director
Signature: /s/ Vaughn C. Embro-Pantalony
Issuer symbol: BCTX
Transactions as of: 01 Aug 2022
Net transactions value: $0
Form type: 3
Filing time: 01 Aug 2022, 16:10:25 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BCTX	Common Shares						9,524	01 Aug 2022	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BCTX	Option (Right to Buy)							01 Aug 2022	Common Shares	25,000	$4.24	Direct
holding	BCTX	Option (Right to Buy							01 Aug 2022	Common Shares	50,000	$8.47	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Common Shares are registered in the name of Strath Management Inc, an entity controlled by the Reporting Person.
F2	The Option vests quarterly for 2 years from the date of grant.